# Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis

> **NCT03961529** · PHASE3 · COMPLETED · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 366 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** 0.3% OPA-15406 ointment
- **DRUG:** 1% OPA-15406 ointment

## Key facts

- **NCT ID:** NCT03961529
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-14
- **Primary completion:** 2020-11-11
- **Final completion:** 2020-11-11
- **Target enrollment:** 366 (ACTUAL)
- **Last updated:** 2021-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03961529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03961529, "Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03961529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*